HEPATITIS B CHRONIC: Clinical Trials

10 trials for HEPATITIS B CHRONIC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 not yet recruiting, 2 recruiting, 1 active not recruiting, 1 withdrawn. 2 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 2
Phase 22Not yet recruiting 1, Withdrawn 1
Early Phase 11Not yet recruiting 1
Phase 11Recruiting 1

Follow HEPATITIS B CHRONIC: new trials by email Literature Review of HEPATITIS B CHRONIC trials Research Report on HEPATITIS B CHRONIC

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness
Wearable Patch-Type Ultrasound Probe, Transient Elastography (FibroScan) - Liver Fibrosis, Liver Cirrhosis
Not yet recruitingSecond Affiliated Hospital of Xi'an Jiaotong University1502026-10-012026-07-21
Bepirovirsen Liver Biopsy Study
Bepirovirsen, Liver biopsy, Optional Liver biopsy - HEPATITIS B CHRONIC, Hepatitis B Chronic Infection
Phase 2Not yet recruitingNational University Health System, Singapore302026-07-012026-07-10
Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis
Babao Dan Capsule, Babao Dan Capsule simulant - HEPATITIS B CHRONIC, Cirrhosis, Liver
Not applicableNot yet recruitingNanfang Hospital, Southern Medical University10342026-04-012026-04-22
Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study
Biejia-Ruangan compound, Biejia-Ruangan compound simulant - Cirrhosis, Liver, Hepatocellular Carcinoma (HCC)
Not applicableNot yet recruitingNanfang Hospital, Southern Medical University10342026-04-012026-03-18
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
Peginterferon alfa-2b, TDF, TAF - Hepatocellular Carcinoma, HEPATITIS B CHRONIC
Early Phase 1Not yet recruitingNingbo No.2 Hospital1562026-03-312026-04-28
Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D
Bulevirtide, No intervention - HEPATITIS B CHRONIC, Hepatitis D
RecruitingResearch Center of Periodontal-Systemic Interactions252026-02-152026-03-25
Comparison of a Handheld Elastography Device With iLivTouch in Chronic Liver Disease Patients
MAFLD, HEPATITIS B CHRONIC
Not yet recruitingHong You2242025-12-012025-11-21
A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B
HEPATITIS B CHRONIC
Active not recruitingJuan Li4002024-12-302026-04-29
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
PBGENE-HBV - HEPATITIS B CHRONIC
Phase 1RecruitingPrecision BioSciences, Inc.452024-11-142026-08-24
A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients
DCB-BO1202, Placebo, DCB-BO1202+Placebo - Liver Fibrosis, HEPATITIS B CHRONIC
Phase 2WithdrawnA2 Healthcare Taiwan Corporation2020-01-012020-01-13

Narrower conditions

Hepatitis B, Chronic (10)  ·  Carcinoma, Hepatocellular (4)  ·  Liver Cirrhosis (4)  ·  Hepatitis B (2)  ·  Hepatitis D (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Periodontitis (1)

Broader conditions

Blood-Borne Infections (10)  ·  Chronic Disease (10)  ·  Communicable Diseases (10)  ·  DNA Virus Infections (10)  ·  Digestive System Diseases (10)  ·  Disease Attributes (10)  ·  Hepadnaviridae Infections (10)  ·  Hepatitis (10)  ·  Hepatitis, Chronic (10)  ·  Hepatitis, Viral, Human (10)  ·  Infections (10)  ·  Liver Diseases (10)  ·  Pathologic Processes (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Virus Diseases (10)

Interventions

babao dan (1)  ·  bulevirtide (1)  ·  peginterferon alfa-2b (1)

Sponsors

Nanfang Hospital, Southern Medical University (2)  ·  A2 Healthcare Taiwan Corporation (1)  ·  Hong You (1)  ·  Juan Li (1)  ·  National University Health System, Singapore (1)  ·  Ningbo No.2 Hospital (1)  ·  Precision BioSciences, Inc. (1)  ·  Research Center of Periodontal-Systemic Interactions (1)  ·  Second Affiliated Hospital of Xi'an Jiaotong University (1)

Countries

China (2)  ·  Romania (2)  ·  France (1)  ·  Hong Kong (1)  ·  Moldova (1)  ·  New Zealand (1)  ·  Singapore (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Kai-Wen Huang, MD (1)  ·  Seng Gee Prof Lim, Professor (1)